Literature DB >> 14755252

The helix-loop-helix protein ID1 localizes to centrosomes and rapidly induces abnormal centrosome numbers.

Jens Hasskarl1, Stefan Duensing, Edwin Manuel, Karl Münger.   

Abstract

ID1 is a member of the inhibitor of DNA binding/differentiation (ID) family of dominant negative helix-loop-helix transcription factors. ID-proteins have been implicated in the control of differentiation and transcriptional modulation of various cell cycle regulators and high levels of ID1 expression are frequently detected in various cancer types. However, it is unclear whether ID1 is a marker of highly proliferative cancer cells or whether it directly contributes to the tumor phenotype. A detailed analysis of ID1-expressing human cells revealed that a fraction of ID1 localizes to centrosomes. Ectopic expression of ID1 in primary cells and tumor cell lines resulted in accumulation of cells with abnormal centrosome numbers. There was no evidence for centrosomal localization or induction of centrosome abnormalities by the other ID family members. Hence, ID1 may contribute to oncogenesis not only by inhibiting transcriptional activity of basic helix-loop-helix transcription factors and abrogate differentiation but also by subverting centrosome duplication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755252     DOI: 10.1038/sj.onc.1207310

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Induction of ID1 expression and apoptosis by the histone deacetylase inhibitor (trichostatin A) in human acute myeloid leukaemic cells.

Authors:  W-P Yu; S A Scott; W-F Dong
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

2.  Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.

Authors:  Jan Harder; Michael J Müller; Matthias Fuchs; Vera Gumpp; Annette Schmitt-Graeff; Richard Fischer; Melanie Frank; Oliver Opitz; Jens Hasskarl
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Tripeptidyl Peptidase II Is Required for c-MYC-Induced Centriole Overduplication and a Novel Therapeutic Target in c-MYC-Associated Neoplasms.

Authors:  Stefan Duensing; Sebastian Darr; Rolando Cuevas; Nadja Melquiot; Anthony G Brickner; Anette Duensing; Karl Münger
Journal:  Genes Cancer       Date:  2010-09

4.  A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention.

Authors:  Nina Korzeniewski; Sarah Wheeler; Payel Chatterjee; Anette Duensing; Stefan Duensing
Journal:  Mol Cancer       Date:  2010-06-17       Impact factor: 27.401

5.  Id1 overexpression induces tetraploidization and multiple abnormal mitotic phenotypes by modulating aurora A.

Authors:  Cornelia Man; Jack Rosa; Y L Yip; Annie Lai-Man Cheung; Y L Kwong; Stephen J Doxsey; S W Tsao
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

6.  Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component gamma-tubulin.

Authors:  Christine L Nguyen; Catherine Eichwald; Max L Nibert; Karl Münger
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

7.  A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons.

Authors:  Albert H Kim; Sidharth V Puram; Parizad M Bilimoria; Yoshiho Ikeuchi; Samantha Keough; Michael Wong; David Rowitch; Azad Bonni
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  A novel role for the deubiquitinase USP1 in the control of centrosome duplication.

Authors:  Jin Ki Jung; Seok-Won Jang; Jung Min Kim
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

9.  Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Authors:  Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Journal:  BMC Cancer       Date:  2009-06-07       Impact factor: 4.430

10.  Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells.

Authors:  Carolin Manthey; Demissew S Mern; Anja Gutmann; Anne J Zielinski; Corinna Herz; Silke Lassmann; Jens Hasskarl
Journal:  BMC Cell Biol       Date:  2010-01-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.